AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $18,000 | -92.9% | 11,259 | -85.4% | 0.00% | – |
| Q3 2018 | $255,000 | -28.8% | 77,105 | -51.3% | 0.00% | – |
| Q2 2018 | $358,000 | +104.6% | 158,292 | +66.3% | 0.00% | -100.0% |
| Q4 2013 | $175,000 | -75.8% | 95,200 | -72.8% | 0.00% | -66.7% |
| Q3 2013 | $723,000 | -68.5% | 349,400 | -61.9% | 0.00% | -62.5% |
| Q2 2013 | $2,294,000 | +1196.0% | 917,507 | +4070.5% | 0.01% | +700.0% |
| Q4 2012 | $177,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |